 |
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
 |
|
|
 |
 |
 |
 |
Enzyme class:
|
 |
E.C.3.1.11.2
- Exodeoxyribonuclease Iii.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
Degradation of double-stranded DNA. It acts progressively in a 3'- to 5'-direction, releasing nucleoside 5'-phosphates.
|
 |
 |
 |
 |
 |
 |
 |
|
 |
|
 |
|
|
Gene Ontology (GO) functional annotation
|
|
|
|
 |
 |
 |
|
 |
 |
 |
 |
|
 |
|
Cellular component
|
intracellular
|
1 term
|
 |
|
Biochemical function
|
nucleic acid binding
|
2 terms
|
 |
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
J Biol Chem
282:14547-14557
(2007)
|
|
PubMed id:
|
|
|
|
|
| |
|
Structure of the dimeric exonuclease TREX1 in complex with DNA displays a proline-rich binding site for WW Domains.
|
|
M.Brucet,
J.Querol-Audí,
M.Serra,
X.Ramirez-Espain,
K.Bertlik,
L.Ruiz,
J.Lloberas,
M.J.Macias,
I.Fita,
A.Celada.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
TREX1 is the most abundant mammalian 3' --> 5' DNA exonuclease. It has been
described to form part of the SET complex and is responsible for the
Aicardi-Goutières syndrome in humans. Here we show that the exonuclease
activity is correlated to the binding preferences toward certain DNA sequences.
In particular, we have found three motifs that are selected, GAG, ACA, and CTGC.
To elucidate how the discrimination occurs, we determined the crystal structures
of two murine TREX1 complexes, with a nucleotide product of the exonuclease
reaction, and with a single-stranded DNA substrate. Using confocal microscopy,
we observed TREX1 both in nuclear and cytoplasmic subcellular compartments.
Remarkably, the presence of TREX1 in the nucleus requires the loss of a
C-terminal segment, which we named leucine-rich repeat 3. Furthermore, we
detected the presence of a conserved proline-rich region on the surface of
TREX1. This observation points to interactions with proline-binding domains. The
potential interacting motif "PPPVPRPP" does not contain aromatic
residues and thus resembles other sequences that select SH3 and/or Group 2 WW
domains. By means of nuclear magnetic resonance titration experiments, we show
that, indeed, a polyproline peptide derived from the murine TREX1 sequence
interacted with the WW2 domain of the elongation transcription factor CA150.
Co-immunoprecipitation studies confirmed this interaction with the full-length
TREX1 protein, thereby suggesting that TREX1 participates in more functional
complexes than previously thought.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 4.
FIGURE 4. Structure of TREX1 in complex with DNA. A, extra
electron density observed in the active center, indicating the
presence of a 4-mer single-stranded DNA (orange atom-type
sticks). The potential surface representation shows the
predominantly negatively charged catalytic center and the region
adjacent to the disordered loop 167-174. B, structure of the
active site in complex with the single-stranded DNA. Residues
responsible for interaction with DNA are depicted in yellow
atom-type sticks. Arg^174, only well structured in monomer B,
and the catalytic residue His^195 mutated to Ala are also shown.
C, TREX1 electrostatic potential surface showing the relative
position of the DNA in complex with the dimer. The dimer
possesses little positive charge except in the regions adjacent
to the active sites. The cleft that connects the two active
sites presents an overall negative charge. D, structural
superimposition of the active site of TREX1 in the presence of a
DNA substrate (cyan) and in the presence of a dTMP nucleotide
(green), product of the exonuclease reaction.
|
 |
Figure 5.
FIGURE 5. DNA interaction with TREX1 and Klenow and
nucleotide interaction with TREX1. A, ribbon diagram
superimposition of TREX1 (cyan) and the exonuclease Klenow
fragment (purple) in complex with single-stranded DNA (4-mer in
TREX1, 3-mer in Klenow, PDB 1KSP), showing that the cores and
most secondary structural elements are conserved. B, model
showing the putative interaction of TREX1 with a double-stranded
DNA (red and orange). The model was constructed by a
superposition of the structure of the Klenow fragment bound to
double-stranded DNA (PDB 1KLN). The regions predicted to be
responsible for DNA binding are indicated (Trp^188 in yellow,
disordered loop in black, and polyproline loop in green).
|
 |
|
|
|
| |
The above figures are
reprinted
by permission from the ASBMB:
J Biol Chem
(2007,
282,
14547-14557)
copyright 2007.
|
|
| |
Figures were
selected
by an automated process.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
W.Yang
(2011).
Nucleases: diversity of structure, function and mechanism.
|
| |
Q Rev Biophys, 44,
1.
|
 |
|
|
|
|
 |
U.de Silva,
F.W.Perrino,
and
T.Hollis
(2009).
DNA binding induces active site conformational change in the human TREX2 3'-exonuclease.
|
| |
Nucleic Acids Res, 37,
2411-2417.
|
 |
|
|
|
|
 |
Y.J.Crow,
and
J.Rehwinkel
(2009).
Aicardi-Goutieres syndrome and related phenotypes: linking nucleic acid metabolism with autoimmunity.
|
| |
Hum Mol Genet, 18,
R130-R136.
|
 |
|
|
|
|
 |
D.A.Lehtinen,
S.Harvey,
M.J.Mulcahy,
T.Hollis,
and
F.W.Perrino
(2008).
The TREX1 double-stranded DNA degradation activity is defective in dominant mutations associated with autoimmune disease.
|
| |
J Biol Chem, 283,
31649-31656.
|
 |
|
|
|
|
 |
F.W.Perrino,
U.de Silva,
S.Harvey,
E.E.Pryor,
D.W.Cole,
and
T.Hollis
(2008).
Cooperative DNA binding and communication across the dimer interface in the TREX2 3' --> 5'-exonuclease.
|
| |
J Biol Chem, 283,
21441-21452.
|
 |
|
|
|
|
 |
M.Brucet,
J.Querol-Audí,
K.Bertlik,
J.Lloberas,
I.Fita,
and
A.Celada
(2008).
Structural and biochemical studies of TREX1 inhibition by metals. Identification of a new active histidine conserved in DEDDh exonucleases.
|
| |
Protein Sci, 17,
2059-2069.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
Y.G.Yang,
T.Lindahl,
and
D.E.Barnes
(2007).
Trex1 exonuclease degrades ssDNA to prevent chronic checkpoint activation and autoimmune disease.
|
| |
Cell, 131,
873-886.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
codes are
shown on the right.
|
|